Kevin Rakin - 17 Feb 2022 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
Director
Signature
/s/ Kevin Rakin
Issuer symbol
ORMP
Transactions as of
17 Feb 2022
Net transactions value
+$5.3
Form type
4
Filing time
22 Feb 2022, 16:30:40 UTC
Previous filing
15 Feb 2022
Next filing
22 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Options Exercise $32,002 +6,667 +13% $4.80 59,671 17 Feb 2022 Direct
transaction ORMP Common Stock Tax liability $31,996 -3,010 -5% $10.63 56,661 17 Feb 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORMP Stock Option (right to buy) Options Exercise $0 -6,667 -100% $0.000000* 0 17 Feb 2022 Common Stock 6,667 $4.80 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a cashless exercise of outstanding stock options to purchase 6,667 shares of common stock. The reporting person received 3,657 shares of common stock and surrendered 3,010 shares of common stock underlying the stock option in payment of the exercise price.